
Sign up to save your podcasts
Or


Katie and Matt discuss tariffs, skeptical questions, nondelegation, major questions, reimbursement, the Metsera deal, amylin targeting, Sam Bankman-Fried’s appeal, alleged fraud at First Brands, factoring due diligence, the blockchain and short memories in the credit market.
See omnystudio.com/listener for privacy information.
By Bloomberg4.8
370370 ratings
Katie and Matt discuss tariffs, skeptical questions, nondelegation, major questions, reimbursement, the Metsera deal, amylin targeting, Sam Bankman-Fried’s appeal, alleged fraud at First Brands, factoring due diligence, the blockchain and short memories in the credit market.
See omnystudio.com/listener for privacy information.

404 Listeners

1,166 Listeners

2,171 Listeners

1,940 Listeners

415 Listeners

353 Listeners

2,456 Listeners

2,358 Listeners

944 Listeners

968 Listeners

796 Listeners

192 Listeners

30 Listeners

517 Listeners

454 Listeners

350 Listeners

4 Listeners

155 Listeners

58 Listeners

233 Listeners

228 Listeners

62 Listeners

82 Listeners

72 Listeners

85 Listeners

33 Listeners

17 Listeners

12 Listeners

8 Listeners

2 Listeners

72 Listeners